Coastal Research Institute - Fayetteville

Clinical research site in Fayetteville, North Carolina

As of July 2026, 2 paid clinical trials are recruiting at Coastal Research Institute - Fayetteville in Fayetteville, North Carolina. Active studies at this site cover conditions such as Obesity or Overweight, Crohn's Disease and Ulcerative Colitis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Coastal Research Institute - Fayetteville (2)

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for Ulcerative Colitis

37 locations incl. Dothan

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 70

Code: NCT06937086·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

for Crohn's Disease

35 locations incl. Dothan

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 70

Code: NCT06937099·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

More research sites in Fayetteville

Cross Creek Medical Clinic (7 trials)
Coastal Research Institute, LLC (4 trials)
89bio Clinical Study Site (2 trials)
Akero Clinical Study Site (2 trials)
Cape Fear Valley Medical Center (2 trials)
Coastal Research Institute (2 trials)
Cross Creek Medical Clinic, PA (2 trials)
GSK Investigational Site (2 trials)
Cape Fear Valley Health System (2 trials)
ACCOMPLISH-1 Research Site (1 trial)

Explore more

Paid clinical trials in Fayetteville, NC · North Carolina clinical trials